Aster DM Healthcare is currently trading at Rs. 119.25, up by 2.15 points or 1.84% from its previous closing of Rs. 117.10 on the BSE.
The scrip opened at Rs. 118.10 and has touched a high and low of Rs. 119.25 and Rs. 118.00 respectively.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 181.75 on 04-Sep-2018 and a 52 week low of Rs. 109.70 on 07-Aug-2019.
Last one week high and low of the scrip stood at Rs. 121.50 and Rs. 113.00 respectively. The current market cap of the company is Rs. 6007.15 crore.
The promoters holding in the company stood at 37.80%, while Institutions and Non-Institutions held 15.28% and 46.92% respectively.
Aster DM Healthcare is setting up Aster Innovation and Research Centre in GCC and India, to improve the ultimate health outcomes for patients and enhance their overall experience at all its facilities. Over the next three years, the Centre will aim to achieve key milestones like introduction of innovative solutions for home healthcare with focus on digital primary care, establishing a rich eco-system of digital health partners from start-ups to academia and starting digital health/ informatics/ medicine as a stream for future healthcare workers.
Aster DM Healthcare operates as a healthcare company in the Middle East, India, and the Far East. It operates hospitals and clinics, pharmacies, diagnostic centers, educational institutions, and healthcare management and healthcare support systems.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7771.45 |
| Max Healthcare Inst | 1007.00 |
| Narayana Hrudayalay | 1796.75 |
| Aster DM Healthcare | 687.80 |
| Global Health | 1110.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: